Safety of red yeast rice supplementation: A systematic review and metaanalysis of randomized controlled trials
Pharmacological Research 143 (2019)
1–16journal homepage:
www.elsevier.com/locate/yphrs
Con posterioridad a la emisión del informe de seguridad de EFSA, en 2019 se publicó el resultado de un meta-análisis (Federica Focacci et alt.) que arroja las siguientes:
6. Conclusions
The present meta-analysis, which included more than 8500 subjects, demonstrates that RYR supplementation is safe and is not associated with increased incidence of muscular adverse effects. On the contrary, our findings shows reduced risk of Non-MuD and SAE, suggesting this nutraceutical compound can be used in order to promote health in general population with mildly increased cardiovascular disease risk and in statin-intolerant patients.
Por razones de Copyright no podemos redistribuir este informe, que puede obtenerse aquí:
doi.org/10.1016/j.phrs.2019.02.028
